The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists

H T Eich; J Kriz; H Schmidberger; B Böll; B Klimm; M Rancea; R-P Müller; A Engert; Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO)

doi:10.1007/s00066-013-0331-4

The German evidence-based guidelines for Hodgkin's lymphoma. Aspects for radiation oncologists

Strahlenther Onkol. 2013 Jun;189(6):445-7. doi: 10.1007/s00066-013-0331-4. Epub 2013 Apr 21.

Authors

H T Eich¹, J Kriz, H Schmidberger, B Böll, B Klimm, M Rancea, R-P Müller, A Engert; Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO)

Affiliation

¹ Department of Radiation Oncology, University of Muenster, Albert-Schweitzer-Campus 1, Münster, Germany. HansTheodor.Eich@ukmuenster.de

PMID: 23604187
DOI: 10.1007/s00066-013-0331-4

Abstract

This report reviews aspects of the German evidence-based guidelines for Hodgkin's lymphoma relevant to radiation oncologists. Stage-adapted treatment is discussed with the focus on radiotherapy. Up-to-date literature citations provide an overview of current recommendations.

Publication types

Practice Guideline

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Cooperative Behavior
Evidence-Based Medicine*
Fluorodeoxyglucose F18
Germany
Hodgkin Disease / diagnostic imaging
Hodgkin Disease / drug therapy
Hodgkin Disease / pathology
Hodgkin Disease / radiotherapy*
Humans
Interdisciplinary Communication
Neoadjuvant Therapy
Neoplasm Staging
Neoplasm, Residual / diagnostic imaging
Neoplasm, Residual / drug therapy
Neoplasm, Residual / pathology
Neoplasm, Residual / radiotherapy
Positron-Emission Tomography
Prognosis
Radiotherapy Dosage

Substances

Fluorodeoxyglucose F18